Globus Medical Inc. (GMED) Financials Nov 17, 2014
Post# of 250674
Posted On: 11/18/2014 8:56:32 AM
Globus Medical Inc. (GMED) Financials Nov 17, 2014, 4:23 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Globus Medical Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 254.34M 288.2M 331.48M 385.99M 434.46M
Cost of Goods Sold (COGS) incl. D&A 41.61M 53.83M 68.8M 75.2M 99.08M
COGS excluding D&A 28.11M 38.63M 51.85M 57.09M 79.69M
Depreciation & Amortization Expense 13.5M 15.2M 16.95M 18.11M 19.4M
Depreciation 13.4M 15.1M 16.9M 17.64M 18.87M
Amortization of Intangibles 102,000 96,000 49,000 468,000 528,000
Gross Income 212.74M 234.37M 262.68M 310.8M 335.38M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 128.94M 143.9M 163.85M 196.79M 209.27M
Research & Development 20.52M 21.31M 23.46M 27.93M 26.87M
Other SG&A 108.42M 122.59M 140.39M 168.86M 182.4M
Other Operating Expense 0 0 0 0 0
Unusual Expense 2.09M 2.99M 1.57M (786,000) 24.44M
EBIT after Unusual Expense (2.09M) (2.99M) (1.57M) 786,000 (24.44M)
Non Operating Income/Expense 73,000 254,000 (313,000) (140,000) 328,000
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense - - - 0 -
Gross Interest Expense - - - 0 -
Interest Capitalized 0 0 0 0 0
Pretax Income 81.78M 87.74M 96.95M 114.65M 102M
Income Tax 29.75M 33.28M 36.17M 40.82M 33.39M
Income Tax - Current Domestic 32.39M 30.93M 33.74M 46.76M 47.86M
Income Tax - Current Foreign 7,000 351,000 373,000 345,000 912,000
Income Tax - Deferred Domestic (2.65M) 2.05M 2.01M (5.86M) (15.3M)
Income Tax - Deferred Foreign 0 (47,000) 47,000 (418,000) (84,000)
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 52.03M 54.46M 60.78M 73.83M 68.61M
Minority Interest Expense 3.3M 0 0 0 0
Net Income 48.73M 54.46M 60.78M 73.83M 68.61M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 48.73M 54.46M 60.78M 73.83M 68.61M
Preferred Dividends 8.62M 9.55M 10.76M 0 0
Net Income Available to Common 40.12M 44.91M 50.03M 73.83M 68.61M
EPS (Basic) 0.55 0.62 0.69 0.82 0.74
Basic Shares Outstanding 88.11M 88.11M 88.11M 89.61M 92.65M
EPS (Diluted) 0.54 0.60 0.67 0.80 0.73
Diluted Shares Outstanding 91.07M 91.07M 91.07M 92.21M 94.19M
EBITDA 97.3M 105.67M 115.78M 132.12M 145.51M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Globus Medical Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 254.34M 288.2M 331.48M 385.99M 434.46M
Cost of Goods Sold (COGS) incl. D&A 41.61M 53.83M 68.8M 75.2M 99.08M
COGS excluding D&A 28.11M 38.63M 51.85M 57.09M 79.69M
Depreciation & Amortization Expense 13.5M 15.2M 16.95M 18.11M 19.4M
Depreciation 13.4M 15.1M 16.9M 17.64M 18.87M
Amortization of Intangibles 102,000 96,000 49,000 468,000 528,000
Gross Income 212.74M 234.37M 262.68M 310.8M 335.38M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 128.94M 143.9M 163.85M 196.79M 209.27M
Research & Development 20.52M 21.31M 23.46M 27.93M 26.87M
Other SG&A 108.42M 122.59M 140.39M 168.86M 182.4M
Other Operating Expense 0 0 0 0 0
Unusual Expense 2.09M 2.99M 1.57M (786,000) 24.44M
EBIT after Unusual Expense (2.09M) (2.99M) (1.57M) 786,000 (24.44M)
Non Operating Income/Expense 73,000 254,000 (313,000) (140,000) 328,000
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense - - - 0 -
Gross Interest Expense - - - 0 -
Interest Capitalized 0 0 0 0 0
Pretax Income 81.78M 87.74M 96.95M 114.65M 102M
Income Tax 29.75M 33.28M 36.17M 40.82M 33.39M
Income Tax - Current Domestic 32.39M 30.93M 33.74M 46.76M 47.86M
Income Tax - Current Foreign 7,000 351,000 373,000 345,000 912,000
Income Tax - Deferred Domestic (2.65M) 2.05M 2.01M (5.86M) (15.3M)
Income Tax - Deferred Foreign 0 (47,000) 47,000 (418,000) (84,000)
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 52.03M 54.46M 60.78M 73.83M 68.61M
Minority Interest Expense 3.3M 0 0 0 0
Net Income 48.73M 54.46M 60.78M 73.83M 68.61M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 48.73M 54.46M 60.78M 73.83M 68.61M
Preferred Dividends 8.62M 9.55M 10.76M 0 0
Net Income Available to Common 40.12M 44.91M 50.03M 73.83M 68.61M
EPS (Basic) 0.55 0.62 0.69 0.82 0.74
Basic Shares Outstanding 88.11M 88.11M 88.11M 89.61M 92.65M
EPS (Diluted) 0.54 0.60 0.67 0.80 0.73
Diluted Shares Outstanding 91.07M 91.07M 91.07M 92.21M 94.19M
EBITDA 97.3M 105.67M 115.78M 132.12M 145.51M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)